WX [WuXi PharmaTech (Cayman)] SC 13D: (Original Filing)
[CUSIP No. 929352102 1]
CPHI [CHINA PHARMAS,] DEF 14C: SCHEDULE 14C INFORMATION Check the appropriate box: []
[SCHEDULE 14C INFORMATION Check the appropriate box: [] Preliminary Information Statement [] [X] Definitive Information Statement CHINA PHARMAS, Payment of Filing Fee (Check the appropriate box): [X] No fee required. [] Feemputed on table below per Exchange Act Rules 14c-5(g) and 0-11. 1) Title of each class of securities to which transaction applies:]
WX [WuXi PharmaTech (Cayman)] SC 13D: CUSIP No. 929352102 1
[CUSIP No. 929352102 1]
CPHI [CHINA PHARMAS,] PRER14C: (Original Filing)
[Payment of Filing Fee (Check the appropriate box): [X] No fee required. [ ] Fee computed on table below per Exchange Act Rules 14c-5(g) and 0-11. 1) Title of each class of securities to which transaction applies: 2) Aggregate number of securities to which transaction applies: 3)] [Name Age Position First Year to Be a Director Zhilin Li 57 Director, President and Chief Executive Officer 2006 Heung Mei Tsui]
CPHI [CHINA PHARMAS,] PRER14C: Payment of Filing Fee (Check the appropriate box):
[Payment of Filing Fee (Check the appropriate box): [X] No fee required. [ ] Fee computed on table below per Exchange Act Rules 14c-5(g) and 0-11. 1) Title of each class of securities to which transaction applies: 2) Aggregate number of securities to which transaction applies: 3)] [Name Age Position First Year to Be a Director Zhilin Li 57 Director, President and Chief Executive Officer 2006 Heung Mei Tsui]
CPHI [CHINA PHARMAS,] PRER14C: (Original Filing)
[SCHEDULE 14C INFORMATION Amendment No. 2 I Check the appropriate box: [X] Preliminary Information Statement [] [] Definitive Information Statement CHINA PHARMAS, Payment of Filing Fee (Check the appropriate box): [X] No fee required. [] Feemputed on table below per Exchange Act Rules 14c-5(g) and 0-11. 1) Title of each class of securities to which] [April 30, 2010 Division ofrporation Finance 100 F Street N.E. Attn: Bryan Pitko Re: China Pharmas, Revised Preliminary Information Statement on Form PRE 14C Filed April 1, 2010 File No.001-34471 Dear Mr. Bryan Pitko,mpanymment Letter Form PRER 14C On behalf of China Pharmas, a Delawarerporation (the]
